UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from________ to ___________ Commission File No. 001-00100 THERAPEUTICSMD, INC. (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdict ...

TherapeuticsMD, Inc. (NASDAQ:TXMD) Q3 2019 Earnings Conference Call November 6, 2019 4:30 PM ET Company Participants Nichol Ochsner - Vice President, Investor Relations Robert Finizio - Chief Executive Officer Dan Cartwright - Chief Financial Officer Dawn Halkuff - Chief Commercial Officer Conference Call Participants Annabel Samimy - Stifel Sudan Naveen Loganathan - Cantor Fitzgerald Ekaterina Knyazkova - JPMorgan Douglas Tsao - HCW Operator Good afternoon, ladies and gentlemen. Thank you for joining us fo ...

1 3Q 2019 Earnings November 6, 2019 Building a Premier Women's Health Portfolio TherapeuticsMD® For Her. For Life. Forward-Looking Statements This presentation by TherapeuticsMD, Inc. (referred to as "we" and "our") may contain forward-looking statements. Forward-looking statements may include, but are not limited to, statements relating to our objectives, plans and strategies, as well as statements, other than historical facts, that address activities, events or developments that we intend, expect, project ...

1 Investor Presentation October 2019 Building a Premier Women's Health Portfolio TherapeuticsMD® For Her. For Life. Forward-Looking Statements This presentation by TherapeuticsMD, Inc. (referred to as "we" and "our") may contain forward-looking statements. Forward-looking statements may include, but are not limited to, statements relating to our objectives, plans and strategies, as well as statements, other than historical facts, that address activities, events or developments that we intend, expect, projec ...

(Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from________ to ___________ Commission File No. 001-00100 THERAPEUTICSMD, INC. (Exact Name of Registrant as Specified in Its Charter) Nevada 87-0233535 (State or Ot ...

TherapeuticsMD, Inc. (NASDAQ:TXMD) Q2 2019 Earnings Conference Call August 6, 2019 4:30 PM ET Company Participants Nichol Ochsner - Vice President of Investor Relations Robert Finizio - Chief Executive Officer Daniel Cartwright - Chief Financial Officer Dawn Halkuff - Chief Commercial Officer Conference Call Participants Louise Chen - Cantor Fitzgerald Annabel Samimy - Stifel Jay Olson - Oppenheimer Operator Good afternoon, ladies and gentlemen. Thank you for joining us for the TherapeuticsMD Second Quarter ...

1 2Q 2019 Earnings August 6, 2019 Building a Premier Women's Health Portfolio TherapeuticsMD® For Her. For Life. Forward-Looking Statements This presentation by TherapeuticsMD, Inc. (referred to as "we" and "our") may contain forward-looking statements. Forward-looking statements may include, but are not limited to, statements relating to our objectives, plans and strategies, as well as statements, other than historical facts, that address activities, events or developments that we intend, expect, project, ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from________ to ___________ Commission File No. 001-00100 FL (Address of Principal Executive Offices) (Zip Code) (561) 961-1900 (Registrant's Telephone Number, includ ...

TherapeuticsMD, Inc. (NASDAQ:TXMD) Q1 2019 Earnings Conference Call May 6, 2019 4:30 PM ET Company Participants Nichol Ochsner - Vice President, Investor Relations Robert Finizio - Chief Executive Officer Daniel Cartwright - Chief Financial Officer Dawn Halkuff - Chief Commercial Officer Conference Call Participants Louise Chen - Cantor Fitzgerald Ken Cacciatore - Cowen Jay Olson - Oppenheimer Annabel Samimy - Stifel Chris Schott - JPMorgan Chris Howerton - Jefferies Operator Good afternoon ladies and gentl ...

| --- | --- | |-------|-------| | | | | | | | | | | | | 1 1 Q 1 9 T X M D U P D AT E Building a Premier Women's Health Portfolio TherapeuticsMD® For Her. For Life. Forward-Looking Statements This presentation by TherapeuticsMD, Inc. (referred to as "we" and "our") may contain forward-looking statements. Forward-looking statements may include, but are not limited to, statements relating to our objectives, plans and strategies, as well as statements, other than historical facts, that address activities, event ...